713018 |
FRONTIERS IN ONCOLOGY |
Piwi-Interacting RNAs: A New Class of Regulator in Human Breast Cancer |
2021-07-06 |
10.3389/fonc.2021.695077 |
Qian Lu, Xie Heying, Zhang Libo, Zhao Qian, Lü Jinhui, Yu Zuoren |
713017 |
FRONTIERS IN ONCOLOGY |
HNRNPH1 Is a Novel Regulator Of Cellular Proliferation and Disease Progression in Chronic Myeloid Leukemia |
2021-07-06 |
10.3389/fonc.2021.682859 |
Liu Menghan, Yang Lin, Liu Xiaojun, Nie Ziyuan, Zhang Xiaoyan, Lu Yaqiong, Pan Yuxia, Wang Xingzhe, Luo Jianmin |
713016 |
FRONTIERS IN ONCOLOGY |
Improvement of Diabetes Mellitus After Colorectal Cancer Surgery: A Retrospective Study of Predictive Factors For Type 2 Diabetes Mellitus Remission and Overall Survival |
2021-07-06 |
10.3389/fonc.2021.694997 |
Peng Dong, Liu Xiao-Yu, Cheng Yu-Xi, Tao Wei, Cheng Yong |
713015 |
FRONTIERS IN ONCOLOGY |
Circular RNA circ-MMP11 Contributes to Lapatinib Resistance of Breast Cancer Cells by Regulating the miR-153-3p/ANLN Axis |
2021-07-06 |
10.3389/fonc.2021.639961 |
Wu Xiaoli, Ren Yi, Yao Rong, Zhou Leilei, Fan Ruihua |
713014 |
FRONTIERS IN ONCOLOGY |
Long Non-Coding RNA LINC00152 Regulates Self-Renewal of Leukemia Stem Cells and Induces Chemo-Resistance in Acute Myeloid Leukemia |
2021-07-06 |
10.3389/fonc.2021.694021 |
Cui Chunhong, Wang Yan, Gong Wenjie, He Haiju, Zhang Hao, Shi Wei, Wang Hui |
713013 |
FRONTIERS IN ONCOLOGY |
Imaging-Genomics in Glioblastoma: Combining Molecular and Imaging Signatures |
2021-07-06 |
10.3389/fonc.2021.699265 |
Liu Dongming, Chen Jiu, Hu Xinhua, Yang Kun, Liu Yong, Hu Guanjie, Ge Honglin, Zhang Wenbin, Liu Hongyi |
713012 |
FRONTIERS IN ONCOLOGY |
Hormone Receptor Status May Impact the Survival Benefit Between Medullary Breast Carcinoma and Atypical Medullary Carcinoma of the Breast: A Population-Based Study |
2021-07-06 |
10.3389/fonc.2021.677207 |
Qin Wenxing, Qi Feng, Guo Mengzhou, Wang Liangzhe, Zang Yuan-Sheng |
713011 |
FRONTIERS IN ONCOLOGY |
m6A Regulator-Mediated Methylation Modification Model Predicts Prognosis, Tumor Microenvironment Characterizations and Response to Immunotherapies of Clear Cell Renal Cell Carcinoma |
2021-07-06 |
10.3389/fonc.2021.709579 |
Xu Wenhao, Tian Xi, Liu Wangrui, Anwaier Aihetaimujiang, Su Jiaqi, Zhu Wenkai, Wan Fangning, Shi Guohai, Wei Gaomeng, Qu Yuanyuan, Zhang Hailiang, Ye Dingwei |
713010 |
FRONTIERS IN ONCOLOGY |
Preoperative Radiomics Analysis of 1p/19q Status in WHO Grade II Gliomas |
2021-07-06 |
10.3389/fonc.2021.616740 |
Fan Ziwen, Sun Zhiyan, Fang Shengyu, Li Yiming, Liu Xing, Liang Yucha, Liu Yukun, Zhou Chunyao, Zhu Qiang, Zhang Hong, Li Tianshi, Li Shaowu, Jiang Tao, Wang Yinyan, Wang Lei |
713009 |
FRONTIERS IN ONCOLOGY |
A Novel Post-Operative ALRI Model Accurately Predicts Clinical Outcomes of Resected Hepatocellular Carcinoma Patients |
2021-07-06 |
10.3389/fonc.2021.665497 |
Liao Minjun, Sun Jiarun, Zhang Qifan, Tang Cuirong, Zhou Yuchen, Cao Mingrong, Chen Tao, Hu Chengguang, Yu Junxiong, Song Yangda, Li Meng, Liao Weijia, Zhou Yuanping |